1 Schatz A, Bugie E, Wakeman SA. Streptomycin, a substance exhibiting Antibiotic Activity Against Gram Positive and Gram Negative Bacteria, Proceedings of Society of Experimental Biology, 1944, 55, 66-69.
2 Hinshaw HC, Feldman WH, Pfuetze KH, Streptomycin in treatment of clinical tuberculosis, American Review of Tuberculosis, 1946, 54, 191-203.
3 Medical Research Council, Streptomycin treatment of pulmonary tuberculosis. Br Med J, 1948; 2: 769-783.
4 Crick B. Chapter 17 Penguin Books, George Orwell, a life. New Edition 1992 539-548.
5 Lehman J. Para-aminosalicylic acid in the treatment of tuberculosis. Lancet, 1946; 1: 15-16.
6 Robitzek EH, Selikoff JT. Hydrazine derivatives of isonicotinic acid in the treatment of active progressive caseous-pneumonic tuberculosis. American review of tuberculosis 1952; 65: 402-425.
7 Rist N, Crofton J. Drug resistance in hospitals and sanitoria. A report to the committee on laboratory methods and to the committee on antibiotics and chemotherapy of the International Union against Tuberculosis, 1960. Bulletin of the International Union against Tuberculosis.
8 Ross JD, Horne NW, Grant JWB, Crofton JW. Hospital treatment of pulmonary tuberculosis. Br Med J 1958; 1: 237-246.
9 Holm CI. Trial by TB. Proceedings of the Royal College of Physicians of Edinburgh Vol 27; Suppl. No 4 1997.
10 Seiler HE, Welstead AG, Williamson J. Report on Edinburgh X-ray campaign 1958. Tubercle 1958; XXXIX, 6: 339-359.